It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.

This information will be published on the database - Disclosure​ UK. 

Disclosure UK is part of a Europe-wide initiative​ to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.

Click to search the database

Please note: the Disclosure UK database does not currently work in Edge. Please search using Chrome, Internet Explorer, Firefox or Safari. 


Disclosure UK update 30 June, 2020

As part of the annual cycle of data verification, the ABPI writes to all individuals and organisations named in companies’ disclosure data ahead of its publication at the end of June. The ABPI has temporarily published 2019 data in a way which minimises any pressure on NHS workers, hospitals and other NHS organisations as they respond to the COVID-19 pandemic. This means that some of the data is not broken down as normal.

In the meantime, individual companies may have published the detailed 2019 data on their own websites where able to lawfully and operationally.

A full technical statement on the temporary change is available here.

We have also held back certain modifications to the data currently published on Disclosure UK which would otherwise have triggered disclosure communications to those NHS workers at this time. If you are a healthcare professional or healthcare organisation and have a question about published disclosure data, please log into the private disclosure portal and raise a query as normal. These queries will be resolved in the usual manner.